Primary Cells and Laboratory Services that lead the way!

Taking the gamble out of your purchase!

Please click on the link for our order form.

Example of a CoA Report Chart for NGS-based Characterization of a Lung Cancer sample

All Products and Services are For Preclinical Research Purposes ONLY!

Customer:……………………………………………………………………………………….. Donor Sample#: Deidentified ………………………………………

Address Line 1:…………………………………………………………………………………. Age:……years

Address Line 2:………………………………………………………………………………… SEX:…………………….

Lab Director:……………………………………………………………………………………. Sample Collection Date: …..-…..-…………

Somatic testing result:

Indication: Lung cancer

Test Amplification Result Mutant fraction%

CDK4 Amplification Detected 5.75 (copies)

CHEK2 c.1245_1246delCAinsTG p.k416E Detected (1.56%)

GNAS c.1398_1399delTGinsCT p.A467S Detected (6.11%)

POLE c.3264delTinsCC p.V1089fs*35 Detected (7.91%)

SMARCA4 c.59delC p.P20fs*23 Detected (28%)

STK11 c.291-2A>T Detected (30.0%)

TP53 c.880G>T p.E294 Detected (40.0%)

PD-L1* Positive (>50%)

ALK fusion* Not Detected

ROS1 fusion Not Detected

NTRK1, NTRK2, NTRK3 fusion* Pending

MSI** Not Detected

Tested by NGS

* Tested by RT-PCT

** Tested by fragments analysis

These results have been reviewed and approved by (name, function)……………………………………………………………………………

Signature: